Ipca Laboratories will hold a meeting of the Board of Directors of the Company on 29 May 2024Powered by Capital Market - Live News

Ipca Laboratories announced that Lyka Labs has allotted to the company 26 lakh equity shares of Rs 10 each representing 7.28% share capital at Rs 139.50 per share including a premium of Rs 129.50 per equity share on conversion of warrants allotted on preferential basis. With this allotment, Ipca Laboratories` shareholding in Lyka Labs is 1,46,24,923 equity shares of Rs. 10/- each representing 40.98% of its paid-up equity share capital, up from 36.34%. Powered by Capital Market - Live News

Ipca Laboratories has appointed Dr Swati Patankar as an Additional Director of the Company with effect from 14 February 2024. Powered by Capital Market - Live News

Ipca Laboratories will hold a meeting of the Board of Directors of the Company on 14 February 2024.Powered by Capital Market - Live News

Ipca Laboratories announced that the Board of Directors of the Company at its meeting held on 10 November 2023, has recommended a Interim dividend of Rs.2 per share (i.e.200%), subject to the approval of the shareholders.Powered by Capital Market - Live News